Pozen isn't a Penny Stock. Penny Stock reports are generally false and misleading.
Until POZEN gets it's problem with the FDA resolved the price will probably drift upward ((very)) slowly.
There should have been some kind of resolution to the supplier by now. However the FDA schedules things out. They do not get things done off a schedule. Their systems prevent them from being efficient and provide them a slow easy work environment. They deal with revieweing complicated science. It has to be this way.